CNSX:BUX

(BUX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume11,500 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive BUX News and Ratings via Email

Sign-up to receive the latest news and ratings for (BUX) and its competitors with MarketBeat's FREE daily newsletter.


About (BUX)

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. It also has a collaborative research and development agreement with Phytronix Technologies Inc. to advance the development of early lung cancer screening applications using Phytronix-proprietary Laser Diode Thermal Desorption technology. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.66 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











(BUX) (CNSX:BUX) Frequently Asked Questions

What stocks does MarketBeat like better than (BUX)?

Wall Street analysts have given (BUX) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but (BUX) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are (BUX)'s key executives?

(BUX)'s management team includes the following people:
  • Mr. Rashid Ahmed Maula Bux, Founder, CEO, Pres & Director
  • Mr. Brian Cheng M.Sc., B.Sc., M.Sc, Chief Technical Officer & Independent Director
  • Gina Huang, CFO & Project Director
  • Dr. Jeff Haince Ph.D., GM & Chief Scientific Officer
  • Neal Kaplan, Chief Financial Officer of US
  • Dr. Daniel Sitar, Principal Scientific Advisor

Who are some of (BUX)'s key competitors?

What other stocks do shareholders of (BUX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (BUX) investors own include Stantec (STN) and IQE (IQE).

What is (BUX)'s stock symbol?

(BUX) trades on the CNSX under the ticker symbol "BUX."

How do I buy shares of (BUX)?

Shares of BUX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is (BUX)'s official website?

The official website for (BUX) is www.biomarkdiagnostics.com.

How can I contact (BUX)?

The company can be reached via phone at 604-370-0779.


This page was last updated on 7/28/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.